Phase ⅡStudy of Pinocembrin Injection to Treat Ischemic Stroke

NCT02059785 · clinicaltrials.gov ↗

PHASE2

Phase

SUSPENDED

Status

216

Enrollment

INDUSTRY

Sponsor class

Conditions

Ischemic Stroke

Interventions

DRUG: Pinocembrin for Injection

Sponsor

CSPC ZhongQi Pharmaceutical Technology Co., Ltd.